Genomics

Dataset Information

50

Expression data from breast cancer FNA biopsies from patients (US samples)


ABSTRACT: This is Phase II Trial of 4courses of 5-fluorouracil, doxorubicin and cyclophosphamide follwed by 4 additional courses of weekly docetaxel and capecitabine administered as Preoperative Therapy for Patients with Locally Advanced Breast Cancer, Stages II and III by US oncology (PROTOCOL 02-103) We performed gene set analysis (GSA) using functionally annotated gene sets corresponding to almost all known biological processes in ER-positive/HER2negative and ER-negative/HER2-negative breast cancer, respectively. Overall design: Pre-treatment FNA from primary tumors were obtained and RNA extracted and hybridized to afymetrix microarrays according to manufacturer protocol.

INSTRUMENT(S): [HG-U133A] Affymetrix Human Genome U133A Array

ORGANISM(S): Homo sapiens  

SUBMITTER: TAKAYUKI IWAMOTO  

PROVIDER: GSE23988 | GEO | 2011-02-07

SECONDARY ACCESSION(S): PRJNA130485

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
GSE23988_RAW.tar Raw
filelist.txt Txt
Items per page:
1 - 2 of 2

Similar Datasets

2011-02-07 | E-GEOD-23988 | ArrayExpress
2010-12-31 | GSE22093 | GEO
2010-12-31 | E-GEOD-22093 | ArrayExpress
2012-12-11 | E-GEOD-42822 | ArrayExpress
2010-09-15 | GSE20271 | GEO
2012-01-17 | E-GEOD-32072 | ArrayExpress
2011-10-31 | E-GEOD-32518 | ArrayExpress
2011-06-22 | GSE23385 | GEO
2011-06-22 | E-GEOD-23385 | ArrayExpress
2011-07-01 | GSE22597 | GEO